Narrative Medicine: A Digital Diary in the Management of Bone and Soft Tissue Sarcoma Patients. Preliminary Results of a Multidisciplinary Pilot Study.

bone and soft tissue sarcoma digital diary digital narrative medicine multidisciplinary team care narrative-based medicine personalized care personalized medicine

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
14 Jan 2022
Historique:
received: 05 11 2021
revised: 11 01 2022
accepted: 12 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 22 1 2022
Statut: epublish

Résumé

Guidelines for the implementation of narrative medicine in clinical practice exist; however, in Italy, no standard methodology is currently available for the management of oncological patients. Since 2017, at the "Regina Elena" National Cancer Institute, studies using "digital narrative diaries" (DNMLAB platform) have been carried out; this article focuses on a pilot, uncontrolled, real-life study aiming to evaluate the utility of DNM integrated with the care pathway of patients with bone and limb soft tissue sarcomas. Adult patients completed the diary during treatment or follow-up by writing their narrative guided by a set of narrative prompts. The endpoints were: (a) patients' opinions about therapeutic alliance, awareness, and coping ability; (b) healthcare professionals' (HCPs') opinions about communication, therapeutic alliance, and information collection. Open- and closed-ended questions (Likert score: 1-5) were used to assess the items. At the interim analysis of data from seven patients and five HCPs, DNM was shown to improve: (a) the expression of patients' point of view, the perception of effective taking charge, disease awareness, and self-empowerment (score: 4.8/5); (b) patients' communication, relationships, and illness knowledge (score: 4.6-4.8/5). The preliminary results supported the need to integrate patients' narratives with clinical data and encourage further research.

Sections du résumé

BACKGROUND BACKGROUND
Guidelines for the implementation of narrative medicine in clinical practice exist; however, in Italy, no standard methodology is currently available for the management of oncological patients. Since 2017, at the "Regina Elena" National Cancer Institute, studies using "digital narrative diaries" (DNMLAB platform) have been carried out; this article focuses on a pilot, uncontrolled, real-life study aiming to evaluate the utility of DNM integrated with the care pathway of patients with bone and limb soft tissue sarcomas.
METHODS METHODS
Adult patients completed the diary during treatment or follow-up by writing their narrative guided by a set of narrative prompts. The endpoints were: (a) patients' opinions about therapeutic alliance, awareness, and coping ability; (b) healthcare professionals' (HCPs') opinions about communication, therapeutic alliance, and information collection. Open- and closed-ended questions (Likert score: 1-5) were used to assess the items.
RESULTS RESULTS
At the interim analysis of data from seven patients and five HCPs, DNM was shown to improve: (a) the expression of patients' point of view, the perception of effective taking charge, disease awareness, and self-empowerment (score: 4.8/5); (b) patients' communication, relationships, and illness knowledge (score: 4.6-4.8/5).
CONCLUSIONS CONCLUSIONS
The preliminary results supported the need to integrate patients' narratives with clinical data and encourage further research.

Identifiants

pubmed: 35054100
pii: jcm11020406
doi: 10.3390/jcm11020406
pmc: PMC8779279
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-iv95
pubmed: 30285218
Acad Med. 2010 Nov;85(11):1669-71
pubmed: 20980850
Eur J Intern Med. 2016 Jul;32:22-5
pubmed: 27210901
Clin Ter. 2010;161(1):9-11
pubmed: 20393672
Epilepsy Behav. 2020 Oct;111:107143
pubmed: 32554233
Eur Heart J. 2019 Mar 7;40(10):800-802
pubmed: 30843596
Recenti Prog Med. 2020 Mar;111(3):154-159
pubmed: 32157263
Acad Med. 2017 Dec;92(12):1665-1667
pubmed: 29019798
Clin Invest Med. 2006 Dec;29(6):351-64
pubmed: 17330451
Perm J. 2018 Apr 18;22:
pubmed: 29702059
Recenti Prog Med. 2018 Jun;109(6):324-327
pubmed: 29968860
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120
pubmed: 26951748
JAMA. 2001 Oct 17;286(15):1897-902
pubmed: 11597295
Acad Med. 2018 Aug;93(8):1105-1106
pubmed: 29443717
BMJ Open. 2020 Jan 26;10(1):e031568
pubmed: 31988222
BMJ Open. 2016 Jul 14;6(7):e011220
pubmed: 27417197

Auteurs

Maria Cecilia Cercato (MC)

Epidemiology and Tumor Registry Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Sabrina Vari (S)

Sarcomas and Rare Tumor Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Gabriella Maggi (G)

Psychology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Wioletta Faltyn (W)

Oncological Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Concetta Elisa Onesti (CE)

Sarcomas and Rare Tumor Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Jacopo Baldi (J)

Oncological Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Alessandra Scotto di Uccio (A)

Oncological Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Irene Terrenato (I)

Biostatistics and Bioinformatics Unit-Scientific Direction, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Claudia Molinaro (C)

Epidemiology and Tumor Registry Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Virginia Scarinci (V)

Digital Library «R. Maceratini», IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Francesca Servoli (F)

Digital Library «R. Maceratini», IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Cristina Cenci (C)

Digital Narrative Medicine (DNM s.r.l.), 00161 Rome, Italy.

Roberto Biagini (R)

Oncological Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Virginia Ferraresi (V)

Sarcomas and Rare Tumor Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Classifications MeSH